Sartorius
keyboard_backspaceBack to Home
Contact
Sartorius Stedim France S.A.S ZI Les Paluds - Av de Jouques - CS 71058
13781 AUBAGNE
France
FIELD ACCOUNT MANAGER
About us
A Trusted Partner of Life Science Research and the Biopharmaceutical Industry.
Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Sartorius is helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So more people will have access to better medicine.
Business offer
Bioprocess solutions & services (USP & DSP):
-CHO cell line development
-Media and buffers
-Bioreactors and fermenters
-Cell and gene therapies
-Filtration (filters, housings, integrity tester, PUPSIT)
Single-use formulation (3D and 2D bags, mixing, storage, transport)
-Aseptic connectors and disconnectors
-Liquid transfer
-Purification
-Chromatography
-Data processing software
-Single use centrifugation
-Final filling (aseptic transfer of liquid and components)
-Freeze and Thaw Process
-Filtration validation
-Validation of extractables and leachables
Activities
- Service
- Technology Supplier
- Training Center
- Consulting
- Cardiology
- Genetic Diseases
- Oncology
- Hematology
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- Other
- CMC
- GLP compliance
- GLP compliance
- Master Cell Bank
- Production
- Cell Line development
- Clone selection
- Characterization
- Storage
- Analytical development
- Cell Culture
- Media composition
- Bioreactor conditions
- Gene modification / Transduction
- Retroviral & lentiviral vectors
- Cell expansion
- Wave-mixed bioreactors
- Stirred tank reactors
- Bioproduction
- Batches production type
- Mammalian
- Insect
- Yeast
- Bacterial
- GLP compliance
- GMP compliance
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Preclinical / Tox
- Low volume (< 200 L)
- High volume (200 – 2000 L)
- Very high volume (> 2000 L)
- Commercial
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- Fill & Finish
- Aseptic filling
- Lyophilization
- Batch release
- Storage matter
- Instruction
- Logistic
- Cell cryopreservation
- Controlled-rated freezer
- thaw
- Quality assurance, quality control & analytical process
- Cell line analytical development
- Host cell proteins
- Viral clearance
- Contaminants detection
- Formulation
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Clinical trials
- Phase I
- Phase II
- Phase III
- Phase IV
- Target cell isolation
- Production Cell
- Bioproduction engineering
- Cell Expansion
- Stirred tank Bioreactor
- Wave bioreactor
- Cell factory
- Microcarrier-based culture
- Organoids culture
- Capsules culture
- Scale-Up
- Process optimization
- Automated manufacturing
- On-line monitoring
- Automated high throughput microbioreactor system
- Non-GMP expansion
- GMP expansion
- Other
- Purification/Extraction
- Filtration / microfiltration / ultrafiltration
- Centrifugation
- Chromatography
- CGMP
- Bioproduction modeling
- Metabolic / Kinetic modeling
- Control / command
- Global optimization
- Economic analyses
- Artificial Intelligence tools
- Formulation
- Conditioning
- Storage
- Delivery
- Transport
- Tracking process
- Monitoring logistics
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Bioproduction
- Scale-Up
- Automated manufacturing
- Automated high throughput microbioreactor system
- Non-GMP pilot batch
- GMP batch
- CGMP
- Sterility
- Quality control
- Vaccine: antigen format platforms
- Recombinant protein expression
- Bacterial
- Cell
- Fungi
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- Killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- CMC
- GLP compliance
- for preclinical NCS (non-clinical safety) studies
- viral safety testing
- GMP compliance
- Master Banks (cell and viral as needed)
- manufacturing
- Characterization and testing
- storage
- shipment
- Cell Culture / Fermentation
- media formulation and supply
- Bioreactor conditions (cell in suspension, adherent cell player)
- Ability to work in BSL2 conditions
- Cell expansion
- Single use technology (SUS)
- Wave-mixed bioreactors
- Stirred tank reactors
- Gene modification / Transduction
- Molecular biology
- Expression systems
- Clinical trials
- Phase I
- Phase II (human challenge trials)
- Phase III (large population pending pathogen prevalence)
- Immune monitoring
- Data management
- Bioproduction GMP
- Vaccine platform type
- Recombinant protein expression
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- Outer-membrane vesicles (OMV)
- Polysaccharides/ conjugated vaccines
- Other
- Pilot Batches scale
- Process development & optimization
- Scale-Up & Validation
- Comparability characterization protocol
- Manufacturing Volume
- Small volume (< 100 L) adjusted to phase I/II needs: specify volume
- Large volume (100 – 1000 L) adapted for phase III needs
- Final scale up volume (> 1000 L) and validation for manufacturing
- Commercial supply during life cycle management
- USP (Scale-Up)
- Fill & finish
- Prefilled syringe
- Vaccine shipment and distribution
- Storage matter
- Cold chain logistics
